Atalay Demiray
Overview
Explore the profile of Atalay Demiray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wahl B, Butin G, Gombe S, Demiray A, Schwalbe N
Health Aff Sch
. 2024 Jul;
2(7):qxae068.
PMID: 39050554
While researchers and agencies from low- and middle-income countries often contribute significantly to public health surveillance data, which is crucial for effective pandemic prevention, preparedness, and response activities, they often...
2.
Copur S, Demiray A, Cherney D, Tuttle K, Kanbay M
Eur J Intern Med
. 2023 Apr;
114:135-137.
PMID: 37045710
No abstract available.
3.
Copur S, Demiray A, Basile C, Kanbay M
J Nephrol
. 2023 Jan;
36(3):885-893.
PMID: 36652168
Acute kidney injury (AKI) is a common comorbidity, affecting approximately one in five hospitalized adults. The kidney is the site for the production, metabolism or excretion of most hormones, including...
4.
Afsar B, Afsar R, Demiray A, Altay S, Korkmaz H, Yildiz A, et al.
Clin Kidney J
. 2022 Jun;
15(7):1275-1283.
PMID: 35756735
Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disease. Recent evidence suggests that the pathogenesis of ADPKD is a complex web of abnormal cellular processes including...
5.
Copur S, Demiray A, Kanbay M
Eur J Intern Med
. 2022 May;
103:4-12.
PMID: 35508444
Increased serum uric acid (SUA) levels are commonly seen in patients with metabolic syndrome and are widely accepted as risk factors for hypertension, gout, non-alcoholic fatty liver disease, chronic kidney...
6.
Ertuglu L, Demiray A, Afsar B, Ortiz A, Kanbay M
Curr Nutr Rep
. 2022 Apr;
11(3):526-535.
PMID: 35476188
Purpose Of Review: With the wide recognition of the importance of dietary patterns rather than isolated nutrient groups on health outcomes, numerous diet quality indices have been designed to evaluate...
7.
Demiray A, Kanbay A, Kanbay M
Clin Kidney J
. 2022 Feb;
15(3):369-371.
PMID: 35198153
During the coronavirus disease 2019 (COVID-19) pandemic, hemodialysis patients constitute one of the most vulnerable patient populations as they have more significant comorbidities and need to visit healthcare settings frequently...
8.
Kanbay M, Copur S, Demiray A, Tuttler K
Curr Nutr Rep
. 2022 Feb;
11(2):347-353.
PMID: 35195849
Purpose Of Review: Health consequences of nighttime eating, as a publicly discussed eating behavior type, have been speculated lately. Nighttime eating has been linked to various metabolic outcomes including hyperlipidemia,...
9.
Kanbay M, Copur S, Demiray A, Sag A, Covic A, Ortiz A, et al.
Eur J Clin Invest
. 2022 Jan;
52(6):e13748.
PMID: 35040119
Background: Metabolic syndrome is a growing twenty-first century pandemic associated with multiple clinical comorbidities ranging from cardiovascular diseases, non-alcoholic fatty liver disease and polycystic ovary syndrome to kidney dysfunction. A...
10.
Demiray A, Kanbay M
Clin Kidney J
. 2022 Jan;
15(1):1-4.
PMID: 35035931
Kidney transplantation (KT) is an increasingly utilized treatment for end-stage kidney disease. Hypertension either as a cause of kidney disease or as a complication of chronic kidney disease is the...